Kiromic BiopharmaÂ Inc (KRBP) Financials

$0.04

$0.00 (0.00%)

As on 13-Jun-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

11.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	8.07	2.80	2.07	0.47	0.20	0.09
Gross Profit	-8.07	-2.80	-2.07	-0.47	-0.20	-0.09
Operating Expenses	23.77	17.14	31.11	25.31	19.20	3.71
Operating Profit (EBIT)	-23.77	-19.94	-31.11	-25.74	-19.20	-3.71
Other Income	--	--	--	--	--	--
Profit before Tax	-26.90	-20.95	-34.73	-25.59	-19.20	-3.73
Provision for Tax	--	0.34	3.45	0.07	0.00	0.02
Profit after Tax (Net Income)	-26.90	-21.29	-38.18	-25.65	-19.20	-3.75
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-34.73	-25.81	-19.20	-3.98

Liabilities ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-12.59	-9.12	-5.77	27.32	11.36	1.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.23	0.91	4.46	0.46	1.13	0.45
Current Liabilities	20.90	20.38	13.28	3.41	1.47	0.67
Total Liabilities	8.55	12.17	11.97	30.73	12.83	2.65

Assets ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	5.24	7.74	10.28	3.66	2.09	0.61
Current Assets	3.30	4.43	1.69	27.07	10.74	2.04
Total Assets	8.55	12.17	11.97	30.73	12.83	2.65
Total Debt*	14.57	15.54	9.41	0.45	0.47	--
Net Current Assets	-17.60	-15.95	-11.59	23.66	9.27	1.37

Cashflow ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	-19.46	-21.23	-23.75	-20.32	-6.13	-2.91
Cash Flow from Investing Activities	-0.37	-0.21	-4.87	-1.81	-1.46	-0.30
Cash from Financing Activities	18.42	23.99	3.90	37.34	15.81	4.76
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.94	-0.65	-55.86	-1.67	-2.62	-0.97
Cash EPS ($)	-0.86	-0.58	-53.41	-1.64	-2.59	-0.94
Adjusted Book Value ($)	--	--	--	1.78	1.55	0.51
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.68	-0.64	-34.74	-1.32	-0.84	-0.75
Free Cash Flow per Share ($)	-0.70	-0.65	-41.88	-1.45	-1.03	-0.83

Profitability Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	-640.22	-423.45	-243.11	-129.55	-278.13	-334.22
ROE (%)	247.82	285.91	-354.43	-132.64	-287.88	-334.22
ROA (%)	-259.71	-176.45	-178.85	-117.79	-248.07	-212.57
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-60.34	44.75	-35.14	-33.23	-418.08	-16.43
Net Profit Growth (%)	-26.32	44.23	-48.83	-33.59	-412.04	1.71
EPS Growth (%)	-0.46	0.99	-32.46	0.36	-1.71	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	-0.95	-1.35	0.00	-0.92	-3.23	--
Price / Book Value	-2.04	-3.14	-0.02	0.86	5.47	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.64	-2.51	-0.27	0.06	-2.76	--
Close Price ($)	0.90	0.87	5.42	45.90	254.10	--
High Price ($)	3.78	8.97	55.80	363.60	555.00	--
Low Price ($)	--	0.16	4.50	44.93	240.30	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	-1.16	-1.70	-1.63	0.02	0.04	--
Short term debt to equity ratio	-1.14	-1.60	-0.86	0.02	0.04	--
Current Ratio	0.16	0.22	0.13	7.94	7.32	3.03
Quick Ratio	--	--	--	--	7.32	3.00
Interest Coverage	-8.22	-10.31	-207.59	-2,096.43	-5,817.24	-164.68

Operating Efficiency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	20.27	80.36
Payable days	108.94	616.88	841.09	1,119.35	1,020.51	1,401.52
Cash Conversion Cycle	--	--	--	--	--	--